Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Füreder

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|June 4, 2011
Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approachesWolfgang Füreder, Peter Valent
Hematology (Amsterdam, Netherlands)|September 20, 2025
Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events - case reportWolfgang Füreder, Andreas Reinisch
Wiener Klinische Wochenschrift|July 2, 2024
Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)Wolfgang Füreder, Renate Thalhammer, Peter Valent
Annals of Hematology|October 13, 2025
Ravulizumab exposure in early pregnancyWolfgang Füreder, Sonja Granser, Andreas Repa, et al.
Annals of Hematology|November 13, 2024
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy- a report of two casesJulia Riedl, Michael Pfeilstöcker, Alex Farr, et al.
Wiener Klinische Wochenschrift|January 21, 2014
Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experienceWolfgang Füreder, Andrea Paulitsch-Buckingham, Werner Rabitsch, et al.
British Journal of Haematology|September 4, 2010
Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuriaAdnan Alahmad, Klaus-Dieter Preuss, Joachim Schenk, et al.
Leukemia Research|May 27, 2017
Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CMLPeter Valent, Emir Hadzijusufovic, Gregor Hoermann, et al.
Wiener Klinische Wochenschrift|October 16, 2016
Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasmWolfgang Füreder, Sabine Cerny-Reiterer, Wolfgang R Sperr, et al.
The American Journal of Pathology|January 10, 2006
Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemiaWolfgang Füreder, Maria-Theresa Krauth, Wolfgang R Sperr, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|June 4, 2011
Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approachesWolfgang Füreder, Peter Valent
Hematology (Amsterdam, Netherlands)|September 20, 2025
Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events - case reportWolfgang Füreder, Andreas Reinisch
Wiener Klinische Wochenschrift|July 2, 2024
Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)Wolfgang Füreder, Renate Thalhammer, Peter Valent
Annals of Hematology|October 13, 2025
Ravulizumab exposure in early pregnancyWolfgang Füreder, Sonja Granser, Andreas Repa, et al.
Annals of Hematology|November 13, 2024
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy- a report of two casesJulia Riedl, Michael Pfeilstöcker, Alex Farr, et al.
Wiener Klinische Wochenschrift|January 21, 2014
Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experienceWolfgang Füreder, Andrea Paulitsch-Buckingham, Werner Rabitsch, et al.
British Journal of Haematology|September 4, 2010
Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuriaAdnan Alahmad, Klaus-Dieter Preuss, Joachim Schenk, et al.
Leukemia Research|May 27, 2017
Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CMLPeter Valent, Emir Hadzijusufovic, Gregor Hoermann, et al.
Wiener Klinische Wochenschrift|October 16, 2016
Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasmWolfgang Füreder, Sabine Cerny-Reiterer, Wolfgang R Sperr, et al.
The American Journal of Pathology|January 10, 2006
Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemiaWolfgang Füreder, Maria-Theresa Krauth, Wolfgang R Sperr, et al.
Pageof 2